BRUKER CORP — Director's Dealing 2021

Sep 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BRUKER CORP (BRKR)
CIK: 0001109354
Period of Report: 2021-09-02

Reporting Person: Srega Juergen (Group President Bruker CALID)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-02	Common Stock	M	90000	$18.57	Acquired	232877	Direct
2021-09-02	Common Stock	M	25369	$20.68	Acquired	258246	Direct
2021-09-02	Common Stock	M	35438	$19.82	Acquired	293684	Direct
2021-09-02	Common Stock	M	39468	$22.19	Acquired	333152	Direct
2021-09-02	Common Stock	S	202216	$89.5397	Disposed	130936	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-02	Stock Option (Right to Purchase)	$18.57	M	90000	Disposed	2023-04-03	Common Stock (90000)	Direct
2021-09-02	Stock Option (Right to Purchase)	$20.68	M	25369	Disposed	2024-08-08	Common Stock (25369)	Direct
2021-09-02	Stock Option (Right to Purchase)	$19.82	M	35438	Disposed	2025-08-07	Common Stock (35438)	Direct
2021-09-02	Stock Option (Right to Purchase)	$22.19	M	39468	Disposed	2026-10-04	Common Stock (39468)	Direct

Footnotes

F1: The stock option granted to the Reporting Person on April 3, 2013 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

F2: The stock option granted to the Reporting Person on August 8, 2014 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

F3: The stock option granted to the Reporting Person on August 7, 2015 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

F4: The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.5014 to $90.15, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.